The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for tividenofusp alfa for the treatment of Hunter syndrome, also known as ...
Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s Hospital, a board member of Project Alive, and the president and founder of ...
After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination ...
New Berlin boy with a rare genetic disease receives his first dose of a newly approved FDA treatment
A 6-year-old New Berlin boy with Hunter syndrome received his first dose of a newly FDA-approved medication, giving his ...
Add Yahoo as a preferred source to see more of our stories on Google. Kim Stephens, her son Cole Stephens Mausolf and their dog, Rosie. Cole, 15, has a form of Hunter syndrome that has a life ...
Jeanette Henriquez, on the left, stands with her two children, Jasmine Henriquez and Dominic Henriquez. Dominic Henriquez was diagnosed with Hunter Syndrome in 2011 before the condition was added to ...
REGENXBIO specializes in gene therapies using proven AAV technology. RGX-121, targets Hunter syndrome and is under FDA review, with a PDUFA date set for November 9, 2025. We believe the upcoming FDA ...
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease First FDA-approved medicine in emerging new class of biotherapeutics that ...
Ever since her 15-year-old son Cole was diagnosed with a rare, progressive illness called Hunter syndrome when he was 2, Kim Stephens has been waiting. Waiting to see if Cole will lose his ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results